Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Allergy Thera. Share Price
  4. Allergy Thera. Share Regulatory News
  5. AGM Statement

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Allergy Thera. Information

Share Price Information for Allergy Thera. (AGY)

Share Price is delayed by 15 minutes
Get Live Data
8.50    0.36 (4.24%)
Bid:
8.00
Ask:
9.00
Spread: 1.00 (12.50%)
Market Cap: £561.06m
AGY Live PriceLast checked at - London Stock Exchange

Intraday Allergy Thera. Share Chart

AGM Statement

16 Nov 2011 17:20

RNS Number : 2463S
Allergy Therapeutics PLC
16 November 2011
 



Wednesday 16 November 2011

 

 

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

 

Result of Annual General Meeting

 

 

Allergy Therapeutics plc announces that at the Annual General Meeting held today, all the resolutions put to that meeting were duly passed.

 

 

For further information

 

Allergy Therapeutics

+44 (0) 1903 844 821

Ian Postlethwaite

Company Secretary

www.allergytherapeutics.com

Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGFFWFWMFFSEFF
12345678910
Date   Source Headline
26th Jun 20239:25 amRNSForm 8.5 (EPT/RI)
23rd Jun 202311:48 amRNSForm 8.5 (EPT/RI)
23rd Jun 202310:48 amBUSForm 8.3 - The Allergy Therapeutics Plc
22nd Jun 20239:55 amBUSForm 8.3 - THE ALLERGY THERAPEUTICS PLC
22nd Jun 20238:45 amRNSForm 8.5 (EPT/RI)
21st Jun 20239:38 amRNSForm 8.5 (EPT/RI)
20th Jun 202312:49 pmRNSForm 8.5 - Allergy Therapeutics plc
20th Jun 20239:57 amBUSForm 8.3 - The Allergy Therapeutics Plc
20th Jun 20239:05 amRNSForm 8.5 (EPT/RI)
19th Jun 20237:30 amRNSRestoration - Allergy Therapeutics PLC
19th Jun 20237:01 amRNSInterim Results and Lifting Suspension in Trading
19th Jun 20237:00 amRNSPublication of Annual Report and Accounts 2022
9th Jun 20237:00 amRNSAllergy Therapeutics shares key findings at EAACI
3rd May 20239:09 amRNSForm 8.3 - Allergy Therapeutics plc
27th Apr 20232:15 pmRNSResult of General Meeting
24th Apr 20237:00 amRNSSouthern Fox: Form 8.3 – Allergy Therapeutics Plc
21st Apr 20237:00 amRNSFORM 8 (OPD) – Allergy Therapeutics plc
20th Apr 20235:29 pmRNSProject Zebra Rule 2.9 Announcement
19th Apr 20237:00 amRNSSkin-prick testing completes in PROTECT Trial
17th Apr 20232:30 pmRNSForm 8 OPD SkyGem Acquisition Limited Replacement
17th Apr 202310:30 amRNSForm 8 (OPD) SkyGem Acquisition Limited
11th Apr 202310:10 amBUSForm 8.3 - The Allergy Therapeutics Plc
6th Apr 20232:01 pmRNSStatement Regarding Possible Mandatory Cash Offer
6th Apr 20232:01 pmRNS£40.75 million Facility with Equity Financing
6th Apr 20232:00 pmRNSTrading and Business Update
29th Mar 20237:00 amRNSPublication of Interim Results Delayed
27th Mar 20237:00 amRNSPatients dosed in VLP Peanut PROTECT trial
8th Mar 20235:28 pmRNSBlock Listing Interim Review
3rd Mar 20237:00 amRNSPDMR Dealing
7th Feb 20236:29 pmRNSResult of AGM
20th Jan 20237:00 amRNSHalf-Year Trading Update 2023
13th Jan 20235:27 pmRNSNOTICE OF 2022 ANNUAL GENERAL MEETING
3rd Jan 20237:30 amRNSSuspension - Allergy Therapeutics plc
29th Dec 202211:05 amRNSSecond Price Monitoring Extn
29th Dec 202211:00 amRNSPrice Monitoring Extension
29th Dec 20229:05 amRNSSecond Price Monitoring Extn
29th Dec 20229:00 amRNSPrice Monitoring Extension
29th Dec 20227:00 amRNSAnnual Report and Accounts Delayed
28th Dec 20227:00 amRNSDirector Resignation
8th Dec 20227:00 amRNSKey updates on Grass MATA MPL and VLP Peanut
6th Dec 20227:00 amRNSAppointment of Non-Executive Directors
21st Nov 20227:00 amRNSAppointment of Interim CFO
28th Oct 20227:00 amRNSAllergy to resume UK manufacturing production
19th Oct 20223:39 pmRNSHolding(s) in Company
17th Oct 20221:27 pmRNSAllergy Therapeutics – Result of GM
4th Oct 20227:00 amRNSUK manufacturing update
29th Sep 202212:00 pmRNSAllergy Therapeutics at Investor Meet Company
29th Sep 20227:00 amRNSSubscription and Debt Financing
29th Sep 20227:00 amRNSUnaudited Preliminary Results 2022
5th Sep 20227:00 amRNSAllergy Therapeutics at H.C. Wainwright Conference
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
STHE
PIMCO US Short-Term High Yield Corporate Bond UCITS ETF EUR Hedged Dist
LSE
-0.22%
ATR
Schroder Asian
LSE
-1.74%
SRP
Serco
LSE
-0.08%
LSAD
LSAD.L
LSE
0.00%
EGU
EGU.L
LSE
0.00%
Trending
MPL
Mercantile Ports & Logistics
LSE
26.92%
AVCT
Avacta Group
LSE
-1.40%
PREM
Premier African Minerals
LSE
-7.61%
HEX
Helix Exploration
LSE
-0.67%
FORG
Forgent
LSE
-5.26%